Skip to content

EV / sales at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
5.1×-0.9×
Agilent Technologies logo
Agilent TechnologiesA
4.8×-0.2×
Danaher logo
DanaherDHR
-0.8×
Quest Diagnostics logo
Quest DiagnosticsDGX
2.4×0.0×
Labcorp Holdings logo
Labcorp HoldingsLH
+0.1×
Abbott logo
AbbottABT
4.6×-1.0×

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$722.7M+15.9%
Operating income$362.6M+14.5%
Net income$278.4M+14.7%
EPS (diluted)$3.47+17.2%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.4%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%
Free cash flow$234.3M+12.7%

Valuation

See full
Market cap$43.08B+31.1%
Enterprise value$43.45B+30.0%
P/E39.3×+2.6×
P/S9.7×+1.3×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Calculated from Idexx Laboratories’s reported figures.

Based on the most recent quarter.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's EV / sales?
Idexx Laboratories (IDXX) reported EV / sales of 10.1× in Q1 2026.
How has Idexx Laboratories's EV / sales changed year-over-year?
Idexx Laboratories's EV / sales increased by 15.0% year-over-year, from 8.8× to 10.1×.
What is the long-term trend for Idexx Laboratories's EV / sales?
Over 4 years (2021 to 2025), Idexx Laboratories's EV / sales has grown at a -9.8% compound annual growth rate (CAGR), from 67.3× to 44.5×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.